Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.4745 EUR -5.1% Market Closed
Market Cap: 19.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Net Income Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Net Income
-€7.8m
CAGR 3-Years
21%
CAGR 5-Years
26%
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Net Income
-$24.9m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
-4%
Galapagos NV
AEX:GLPG
Net Income
€282.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Net Income
-€19m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Net Income?
Net Income
-7.8m EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Net Income amounts to -7.8m EUR.

What is Celyad Oncology SA's Net Income growth rate?
Net Income CAGR 5Y
26%

Over the last year, the Net Income growth was 75%. The average annual Net Income growth rates for Celyad Oncology SA have been 21% over the past three years , 26% over the past five years .

Back to Top